Close Menu

NEW YORK – Natera reported after the close of the market on Wednesday that its fourth quarter 2019 revenues grew 24 percent year over year, while full-year revenues climbed 17 percent.

2019 "was clearly a transformational year for us across all focus areas," said Steve Chapman, the firm's CEO, on a conference call to discuss the financial results. "We delivered financial results above the top of our previous guidance."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.